Wide Ranks

LMAT

LeMaitre Vascular, Inc.

105.80

Top Statistics
Market Cap 2 B Forward PE 49.01 Revenue Growth 15.60 %
Current Ratio 7.74 Trailing PE 58.13 Earnings Growth 48.50 %
Profit Margins 19.40 % Peg Ratio Dividend Yield 0.60 %
Enterprice / EBITA 38.37 Enterprise / Revenue 10.67 Price To Sales Trailing12 Months 11.17
Profitability
Profit Margins 19.40 % Operating Margins 23.98 %
Balance Sheet
Total Cash 123 M Total Cash Per Share 5.51 Total Debt 18 M
Total Debt To Equity 5.54 Current Ratio 7.74 Book Value Per Share 14.72
All Measures
Short Ratio 560.00 % Message Board Id finmb_2567538 Fax 781 221 2223
Shares Short Prior Month 1 M Return On Equity 0.1333 City Burlington
Uuid 28d61f2c-4092-3ada-aee0-a8b5dc08f289 Previous Close 105.42 First Trade Date Epoch Utc 1 B
Book Value 14.72 Beta 0.8850 Total Debt 18 M
Volume 83896 Price To Book 7.19 Fifty Two Week Low 51.70
Total Cash Per Share 5.51 Total Revenue 213 M Shares Short Previous Month Date 1 B
Target Median Price 100.00 Audit Risk 3 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins 23.98 % Last Dividend Value 0.1600
Target Mean Price 98.78 Net Income To Common 41 M Short Percent Of Float 0.0448
Implied Shares Outstanding 22 M Trailing Peg Ratio 232.17 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 111820 Average Volume10days 111820 Total Cash 123 M
Next Fiscal Year End 1 B Revenue Per Share 9.51 Held Percent Insiders 0.0885
Ebitda Margins 27.81 % Dividend Rate 0.6400 Trailing PE 58.13
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 7
Regular Market Previous Close 105.42 Target Low Price 85.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 94.86 Open 106.27 Dividend Yield 0.60 %
State MA Free Cashflow 22 M Return On Assets 0.0872
Time Zone Short Name EST Board Risk 8 Trailing Eps 1.82
Day Low 104.83 Address1 63 Second Avenue Trailing Annual Dividend Rate 0.6200
Compensation Risk 5 Price Hint 2 Shares Outstanding 22 M
Target High Price 117.00 Website https://www.lemaitre.com 52 Week Change 1.01
Average Volume 117570 Earnings Quarterly Growth 48.50 % Forward Eps 2.17
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 532.20 %
Is_sp_500 False Regular Market Day High 106.60 Profit Margins 19.40 %
Debt To Equity 5.54 Fifty Two Week High 109.58 Day High 106.60
Shares Short 756312 Regular Market Open 106.27 Industry Key medical-instruments-supplies
Earnings Growth 48.50 % Enterprise To Revenue 10.67 Revenue Growth 15.60 %
Shares Percent Shares Out 0.0336 Operating Cashflow 39 M Five Year Avg Dividend Yield 95.00 %
Currency USD Market Cap 2 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 01803 Payout Ratio 34.07 %
Quote Type EQUITY Industry Medical Instruments & Supplies Ex Dividend Date 1 B
Overall Risk 6 Regular Market Day Low 104.83 Held Percent Institutions 0.9431
Long Name LeMaitre Vascular, Inc. Enterprise To Ebitda 38.37 Current Price 105.80
Trailing Annual Dividend Yield 0.59 % Financial Currency USD Current Ratio 7.74
Gross Margins 68.34 % Industry Disp Medical Instruments & Supplies Number Of Analyst Opinions 9
Country United States Float Shares 20 M Two Hundred Day Average 81.13
Governance Epoch Date 1 B Enterprise Value 2 B Price To Sales Trailing12 Months 11.17
Forward PE 49.01 Regular Market Volume 83896 Last Dividend Date 1 B
Ebitda 59 M Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide.

It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries.

In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin.

Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures.

It markets its products through a direct sales force and distributors.

The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001.

LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.